Chronic administration of the 5-HT(1A) receptor agonist 8-OH-DPAT differentially desensitizes 5-HT(1A) autoreceptors of the dorsal and median raphe nuclei

Synapse

Volumn 25, Issue 2, 1997, Pages 107-116

  Kreiss, Deborah S ^a,b   Lucki, Irwin ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

5 HT(1A) autoreceptors; 8 OH DPAT; azapirones; desensitization; serotonin release

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; 5 HYDROXYINDOLEACETIC ACID; AUTORECEPTOR; CHLORAL HYDRATE; SEROTONIN 1A AGONIST; SEROTONIN 1A RECEPTOR; SEROTONIN CREATININE SULFATE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CONTROLLED STUDY; CORPUS STRIATUM; DORSAL RAPHE NUCLEUS; HIPPOCAMPUS; INTRAPERITONEAL DRUG ADMINISTRATION; LONG TERM CARE; MALE; MEDIAN RAPHE NUCLEUS; MICRODIALYSIS; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR DOWN REGULATION; SEROTONIN RELEASE; SUBCUTANEOUS DRUG ADMINISTRATION;

8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; ANIMALS; AUTORECEPTORS; MALE; RAPHE NUCLEI; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, SEROTONIN;

EID: 0030942573     PISSN: 08874476     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2396(199702)25:2<107::AID-SYN1>3.0.CO;2-G     Document Type: Article

References (52)

1. Auerbach, S.B., Minzenberg, M.J., and Wilkinson, L.O. (1989) Extracellular serotonin and 5-hydroxyindoleacetic acid in hypothalamus of the unanesthetized rat measured by in vivo dialysis coupled to high-performance liquid chromatography with electrochemical detection: Dialysate serotonin reflects neuronal release. Brain Res., 499:281-290.
2. 3H]8-OH-DPAT and increases the effect of raphe stimulation on 5-HT metabolism. Eur. J. Pharmacol., 178:179-187.
3. 1A agonist gepirone: Electrophysiological studies in the rat brain. Synapse, 1:470-480.
4. 1A receptor agonists. J. Cardiovasc. Pharmacol. [Suppl.], 15:542-548.
5. 1 receptor agonists and p-chloroamphetamine. Synapse, 5:120-133.
6. 1A autoreceptors. Neuropharmacology, 32:527-534.
7. Bonvento, G., Scatton, B., Claustre, Y., and Rouquier, L. (1992) Effect of local injection of 8-OH-DPAT into the dorsal or median raphe nuclei on extracellular levels of serotonin in serotonergic projection areas in the rat brain. Neurosci. Lett., 137:101-104.
8. Caccia, S., Cappi, M. Fracasso, C., and Garattini, S. (1990) Influence of dose and route of administration on the kinetics of fluoxetine and its metabolite norfluoxetine in the rat. Psychopharmacology (Berlin), 100:509-514.
9. 2 agonists. Br. J. Pharmacol., 89:377-384.
10. 1A receptor binding sites following chronic treatment with ipsapirone measured by quantitative autoradiography. Synapse, 12:75-85.
11. Gobbi, M., Lavanus, S., Miari, A., and Mennni, T. (1991). Effect of acute and chronic administration of buspirone on serotonin and benzodiazepine receptor subtypes in the rat brain: An autoradiographic study. Neuropharmacology, 30:313-321.
12. Godbout R., Chaput, Y., Blier, P., and de Montigny, C. (1991) Tandospirone and its metabolite, 1-(2-pyrimidinyl)-piperazine-I. Effects of acute and long-term administration of tandospirone on serotonin transmission. Neuropharmacology, 30:679-690.
13. Goldberg, H.L., and Finnerty, R.J. (1979) The comparative efficacy of buspirone and diazepam in the treatment of anxiety. Am. J. Psychiatry, 136:1184-1187.
14. 1A agonists with potential anxiolytic properties. J. Pharmacol. Exp. Ther., 246:745-752.
15. 1A autoreceptor agonists. Eur. J. Pharmacol., 199:237-242.
16. 1A autoreceptor blockade potentiates the ability of the 5-HT reuptake inhibitor citalopram to increase nerve terminal output of 5-HT in vivo: A microdialysis study. J. Neurochem., 60:776-779.
17. 1A receptor agonist 8-OH-DPAT on the release of 5-HT in dorsal and median rapheinnervated rat brain regions as measured by in vivo microdialysis. Life Sci., 48:1779-1786.
18. Invernizzi, R., Carli, M., Di Clemente, A., and Samanin, R. (1991) Administration of 8-hydroxy-2-(di-n-propylamino)tetralin in raphe nuclei dorsalis and medianus reduces serotonin synthesis in the rat brain: Differences in potency and regional sensitivity. J. Neurochem., 56:243-247.
19. Invernizzi, R., Belli, S., and Samanin, R. (1992) Citalopram's ability to increase the extracellular concentrations of serotonin in the dorsal raphe prevents the drug's effect in the frontal cortex. Brain Res., 584:322-324
20. Jacobs, B.L., and Fornal, C.A. (1991) Activity of brain serotonergic neurons in the behaving animal. Pharmacol. Rev., 43:563-578.
21. Kalen, P., Strecker, R.E., Rosengren, E., and Bjorklund, A. (1988) Endogenous release of neuronal serotonin and 5-hydroxyindoleacetic acid in the caudate-putamen of the rat as revealed by intracerebral dialysis coupled to high performance liquid chromatography with fluorimetric detection. J. Neurochem., 51:1422-1435.
22. 1A presynaptic, but not postsynaptic receptor mediated responses: A relationship to anti-depressant action. Eur. J. Pharmacol., 138:53-60.
23. 1A autoreceptors by chronic administration with 8-OH-DPAT. Neuropharmacology, 31:1073-1075.
24. 1A autoreceptors of the dorsal and median raphe nuclei. J. Pharmacol. Exp. Ther., 269:1268-1279.
25. Kreiss, D.S., and Lucki, I. (1995) Effects of acute and repeated administration of antidepressant drugs on extracellular levels of 5-hydroxytryptamine measured in vivo. J. Pharmacol. Exp. Ther., 274:866-876.
26. Kreiss, D.S., Weiland, S., and Lucki, I. (1993) The presence of a serotonin uptake inhibitor alters pharmacological manipulations of serotonin release. Neuroscience, 52:295-301.
27. 1A receptor agonist 8-OH-DPAT. Neuropharmacology, 29:85-91.
28. Lucki, I. (1991) Behavioral studies of serotonin receptor agonists as antidepressant drugs. J. Clin. Psychiatry [Suppl.], 52:24-31.
29. 1A autoreceptor response and its evaluation as a model to selectively identify antidepressants. Br. J. Pharmacol., 107:15-21.
30. 1 recognition site. Eur. J. Pharmacol., 90:151-153.
31. 1A binding sites are not down-regulated by agonists which induce tolerance in the rat: Myoclonus and other serotonergic behaviors. J. Recept. Res., 12:287-297.
32. Pazos, A., and Palacios, J.M. (1985) Quantitative autoradiographic mapping of serotonin receptors in the rat brain: I. Serotonin-1 receptors. Brain Res., 346:205-230.
33. Paxinos, G., and Watson, C. (1986) The Rat Brain in Stereotaxic Coordinates. Academic Press, New York.
34. Peroutka, S.J. (1985) Selective interaction of novel anxiolyitcs with 5-hydroxytryptamine receptors. Biol. Psychiatry, 20:971-979.
35. Perry, K.W., and Fuller, R.W. (1989) Determination of brain concentrations of 8-hydroxY-2-(di-n-propylamino) tetralin by liquid chromatography with electrochemical detection. Biochem. Pharmacol., 38:3169-3173.
36. Rickels, K., Weisman, K., Norstad, N., Singer, M., Stoltz, D., Brown, A., and Danton, J. (1982) Buspirone and diazepam in anxiety: A controlled study. J. Clin. Psychiatry, 43:81-86.
37. Rickels, K., Amsterdam, J.D., Clary, C., Puzzuoli, G., and Schweizer, E. (1991) Buspirone in major depression: A controlled study. J. Clin. Psychiatry, 52:34-38.
38. 1A partial agonists in depression: A composite analysis of buspirone in the treatment of depression. J. Clin. Psychopharmacol., 10:67-76.
39. Schechter, L.E., Bolaños, F.J., Gozlan, H., Lanfumey, L., Haj-Dahmane, S., Laporte, A.-M., Fattaccini, C.M., and Hamon, M. (1990) Alterations of central serotoninergic and dopaminergic neurotransmission in rats chronically treated with ipsapirone: Biochemical and electrophysiological studies. J. Pharmacol. Exp. Ther., 255:1335-1347.
40. Sharp, T., Bramwell, S.R., Clark, D., and Grahame-Smith, D.G. (1989a) In vivo measurement of the extracellular 5-hydroxytryptamine in hippocampus of the anesthetized rat using microdialysis: Changes in relation to 5-hydroxytryptaminergic neuronal activity. J. Neurochem., 53: 234-240.
41. 1 agonists reduce 5-hydroxytryptamine release in rat hippocampus in vivo as determined by brain microdialysis. Br. J. Pharmacol., 96:283-290.
42. Sharp, T., Bramwell, S.R., Hjorth, S., and Grahame-Smith, D.G. (1989c) Pharmacological characterization of 8-OH-DPAT-induced inhibition of rat hippocampal 5-HT release in vivo as measured by microdialysis. Br. J. Pharmacol., 98:989-997
43. 1A receptor agonists on 5-HT release in rat brain in vivo. Naunyn Schmiedebergs Arch. Pharmacol., 348:339-346.
44. 1 receptor. Eur. J. Pharmacol., 157:173-181.
45. 1A selective agonists. Eur. J. Pharmacol., 128:295-298.
46. 1A receptor-related anxiolytics. Trends Pharmacol. Sci., 8:432-437.
47. VanderMaelen, C.P., Matheson, G.K., Wilderman, R.C., and Patterson, L.A. (1986) Inhibition of serotonergic dorsal raphe neurons by systemic and iontophoretic administration of buspirone, a non-benzodiazepine anxiolytic drug. Eur. J. Pharmacol., 129:123-130.
48. 1A subtype. Eur J. Pharmacol., 113:463-464.
49. 1A binding sites on serotonin containing neurons in the raphe dorsalis and raphe centralis nuclei of the rat brain. Neurochem. Int., 7:1061-1072.
50. 1A receptors in rat brain following antidepressant drug treatment. Synapse, 4:347-352.
51. Wieland, S., Fischette, C., and Lucki, I. (1993) Effect of chronic treatments with tandospirone and imipramine on serotonin-mediated behavioral responses and monoamine receptors. Neuropharmacology, 32:561-573.
52. Wiklund, L., Léger, L., and Persson, M. (1981) Monoamine cell distribution in the cat brain stem. A fluorescence histochemical study with quantification of indolaminergic and locus coeruleus cell groups. J. Comp. Neurol., 203:613-647.